Romark Global Pharma

Manati, PR (2018)

Romark Global Pharma

Business Development, Community, Disaster Recovery, Healthcare, Irma, Manufacturing, Maria

NMTC financing supported the rehabilitation of a former warehouse into a 40,000 square foot pharmaceutical manufacturing plant where it produces Alinia, a prescription drug that treats illnesses caused by Crypotsporidium parvum and Giardia lamblia.

Investment

NMTC Amount: $31,500,000
Total Project Cost: $46,183,551

IMPACT

147 FTE jobs
86 construction jobs
40,000 sq. ft. of real estate

CDEs

Capital One, Grow America, Mid-City Community CDE, Stonehenge Community Development, TruFund

Investor

Capital One

Project Description

Romark Global Pharma, LLC (Romark) used NMTC financing to rehabilitate a former warehouse into a 40,000 sq. ft. pharmaceutical manufacturing plant where it produces Alinia, a prescription drug that treats illnesses caused by Crypotsporidium parvum and Giardia lamblia. This project will contribute to disaster relief efforts following Hurricane Maria.